These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30277108)

  • 1. Granulocyte colony-stimulating factor and respiratory status of critically ill neutropenic patients with hematologic malignancies.
    Mignard X; Biard L; Lemiale V; Mokart D; Pène F; Kouatchet A; Mayaux J; Vincent F; Nyunga M; Bruneel F; Rabbat A; Lebert C; Perez P; Meert AP; Benoit D; Hamidfar R; Darmon M; Azoulay E; Zafrani L
    Leuk Lymphoma; 2019 May; 60(5):1156-1163. PubMed ID: 30277108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for acute respiratory distress syndrome during neutropenia recovery in patients with hematologic malignancies.
    Rhee CK; Kang JY; Kim YH; Kim JW; Yoon HK; Kim SC; Kwon SS; Kim YK; Kim KH; Moon HS; Park SH; Kim HJ; Lee S; Song JS
    Crit Care; 2009; 13(6):R173. PubMed ID: 19886984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group.
    Yoshida M; Karasawa M; Naruse T; Fukuda M; Hirashima K; Oh H; Ninomiya H; Abe T; Saito K; Shishido H; Moriyama Y; Shibata A; Motoyoshi K; Nagata N; Miura Y
    Int J Hematol; 1999 Feb; 69(2):81-8. PubMed ID: 10071455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of colony-stimulating factor therapy on clinical outcome and frequency rate of nosocomial infections in intensive care unit neutropenic patients.
    Gruson D; Hilbert G; Vargas F; Valentino R; Chene G; Boiron JM; Reiffers J; Gbikpi-Benissan G; Cardinaud JP
    Crit Care Med; 2000 Sep; 28(9):3155-60. PubMed ID: 11008974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcutaneous versus intravenous granulocyte colony stimulating factor for the treatment of neutropenia in hospitalized hemato-oncological patients: randomized controlled trial.
    Paul M; Ram R; Kugler E; Farbman L; Peck A; Leibovici L; Lahav M; Yeshurun M; Shpilberg O; Herscovici C; Wolach O; Itchaki G; Bar-Natan M; Vidal L; Gafter-Gvili A; Raanani P
    Am J Hematol; 2014 Mar; 89(3):243-8. PubMed ID: 24178750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
    Ghalaut PS; Sen R; Dixit G
    J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of neutropenia on mortality of critically ill cancer patients: results of a meta-analysis on individual data.
    Georges Q; Azoulay E; Mokart D; Soares M; Jeon K; Oeyen S; Rhee CK; Gruber P; Ostermann M; Hill QA; Depuydt P; Ferra C; Toffart AC; Schellongowski P; Müller A; Lemiale V; Tinquaut F; Bourmaud A; Darmon M
    Crit Care; 2018 Dec; 22(1):326. PubMed ID: 30514339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of Granulocyte Colony-Stimulating Factor in Hospitalized Infants with Neutropenia.
    Lee JA; Sauer B; Tuminski W; Cheong J; Fitz-Henley J; Mayers M; Ezuma-Igwe C; Arnold C; Hornik CP; Clark RH; Benjamin DK; Smith PB; Ericson JE;
    Am J Perinatol; 2017 Apr; 34(5):458-464. PubMed ID: 27649291
    [No Abstract]   [Full Text] [Related]  

  • 9. Outcomes in adult critically ill cancer patients with and without neutropenia: a systematic review and meta-analysis of the Groupe de Recherche en Réanimation Respiratoire du patient d'Onco-Hématologie (GRRR-OH).
    Bouteloup M; Perinel S; Bourmaud A; Azoulay E; Mokart D; Darmon M;
    Oncotarget; 2017 Jan; 8(1):1860-1870. PubMed ID: 27661125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of G-CSF mobilized granulocyte transfusions in four neutropenic children with sepsis and invasive fungal infection.
    Grigull L; Schrauder A; Schmitt-Thomssen A; Sykora K; Welte K
    Infection; 2002 Oct; 30(5):267-71. PubMed ID: 12382084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutropenic sepsis is associated with distinct clinical and biological characteristics: a cohort study of severe sepsis.
    Reilly JP; Anderson BJ; Hudock KM; Dunn TG; Kazi A; Tommasini A; Charles D; Shashaty MG; Mikkelsen ME; Christie JD; Meyer NJ
    Crit Care; 2016 Jul; 20(1):222. PubMed ID: 27431667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte transfusions in critically ill children with prolonged neutropenia: side effects and survival rates from a single-center analysis.
    Weingarten C; Pliez S; Tschiedel E; Grasemann C; Kreissig C; Schündeln MM
    Eur J Pediatr; 2016 Oct; 175(10):1361-9. PubMed ID: 27631588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory status deterioration during G-CSF-induced neutropenia recovery.
    Karlin L; Darmon M; Thiéry G; Ciroldi M; de Miranda S; Lefebvre A; Schlemmer B; Azoulay E
    Bone Marrow Transplant; 2005 Aug; 36(3):245-50. PubMed ID: 15937498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biosimilar granulocyte colony-stimulating factor is effective in reducing the duration of neutropenia after autologous peripheral blood stem cell transplantation.
    Cioch M; Jawniak D; Kotwica K; Wach M; Mańko J; Gorący A; Klimek P; Mazurkiewicz E; Jarosz P; Hus M
    Transplant Proc; 2014 Oct; 46(8):2882-4. PubMed ID: 25380941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of granulocyte/colony-stimulating factor on the onset of the adult respiratory distress syndrome.
    Takahashi Y; Kobayashi Y; Chikayama S; Ikeda M; Kondo M
    Acta Haematol; 1999; 101(3):124-9. PubMed ID: 10352330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of severe neutropenia due to Felty's syndrome or systemic lupus erythematosus with granulocyte colony-stimulating factor.
    Hellmich B; Schnabel A; Gross WL
    Semin Arthritis Rheum; 1999 Oct; 29(2):82-99. PubMed ID: 10553980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute respiratory distress syndrome during neutropenia recovery.
    Azoulay E; Darmon M
    Crit Care; 2010; 14(1):114. PubMed ID: 20236481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exacerbation with granulocyte colony-stimulating factor of prior acute lung injury during neutropenia recovery in rats.
    Azoulay E; Attalah H; Yang K; Herigault S; Jouault H; Brun-Buisson C; Brochard L; Harf A; Schlemmer B; Delclaux C
    Crit Care Med; 2003 Jan; 31(1):157-65. PubMed ID: 12545010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of benefit of granulocyte macrophage or granulocyte colony stimulating factor in patients with febrile neutropenia.
    Siddiqui T; Burney IA; Kakepoto GN; Khurshid M; Salam A; Smego RA
    J Pak Med Assoc; 2002 May; 52(5):206-10. PubMed ID: 12174492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.